Contrast-enhanced ultrasound of malignant liver lesions
Sign Up to like & getrecommendations! Published in 2017 at "Abdominal Radiology"
DOI: 10.1007/s00261-017-1360-8
Abstract: Contrast-enhanced ultrasound (CEUS) is a safe, relatively inexpensive, and widely available imaging technique using dedicated imaging ultrasound sequences and FDA-approved contrast microbubbles that allow detection and characterization of malignant focal liver lesions with high diagnostic… read more here.
Keywords: contrast; malignant liver; enhanced ultrasound; contrast enhanced ... See more keywords
Feasibility and safety of a novel indwelling catheter system via the femoral artery for intermittent transarterial therapy for treating malignant liver tumors
Sign Up to like & getrecommendations! Published in 2021 at "Japanese Journal of Radiology"
DOI: 10.1007/s11604-021-01202-9
Abstract: An indwelling arterial access system via the brachial artery, System-i, has been previously reported. We have modified the technique for the femoral artery approach. This study aimed to evaluate the feasibility and safety of the… read more here.
Keywords: artery; system; malignant liver; indwelling catheter ... See more keywords
Quality of end‐of‐life care with non‐malignant liver disease: Analysis of the VOICES National Survey of Bereaved People
Sign Up to like & getrecommendations! Published in 2022 at "Liver International"
DOI: 10.1111/liv.15428
Abstract: Patients with liver disease struggle to access palliative care. We aimed to compare carers' perceptions of end‐of‐life care for decedents with non‐malignant liver disease, malignant liver disease and other non‐malignant diseases, and to identify associated… read more here.
Keywords: disease; malignant liver; non malignant; care ... See more keywords
Feline primary nonhematopoietic malignant liver tumors: A multicenter retrospective study (2000-2021).
Sign Up to like & getrecommendations! Published in 2023 at "Veterinary and comparative oncology"
DOI: 10.1111/vco.12874
Abstract: There is scant literature on primary nonhematopoietic malignant liver tumors (PMLT) in cats. In this retrospective study, medical data of 40 cats diagnosed with PMLT were reviewed over a period of 22 years (2000-2021). The most… read more here.
Keywords: primary nonhematopoietic; liver; retrospective study; liver tumors ... See more keywords
Pitfalls in contrast enhanced ultrasound: lack of washout in malignant liver lesions. A scoping review.
Sign Up to like & getrecommendations! Published in 2025 at "Minerva medica"
DOI: 10.23736/s0026-4806.25.09658-2
Abstract: Contrast-enhanced ultrasound (CEUS) is a reliable examination procedure to differentiate benign and malignant liver lesions, which is superior to contrast enhanced computed tomography (CECT) and equally to contrast enhanced magnetic resonance imaging (CEMRI) in large… read more here.
Keywords: late phase; contrast enhanced; liver lesions; liver ... See more keywords
Focusing on discoidin domain receptors in premalignant and malignant liver diseases
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1123638
Abstract: Discoidin domain receptors (DDRs) are receptor tyrosine kinases on the membrane surface that bind to extracellular collagens, but they are rarely expressed in normal liver tissues. Recent studies have demonstrated that DDRs participate in and… read more here.
Keywords: discoidin domain; liver; premalignant malignant; malignant liver ... See more keywords
Can Emax and platelet count truly differentiate between benign and malignant liver lesions?
Sign Up to like & getrecommendations! Published in 2025 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v31.i3.98758
Abstract: This letter critically evaluates Jiang et al's article on the differentiation of benign and malignant liver lesions using Emax and platelet count. Despite notable findings, significant methodological and interpretative limitations are identified. The study lacks… read more here.
Keywords: platelet count; liver lesions; benign malignant; malignant liver ... See more keywords
Concomitant determination of hematological indices supported the application of the albumin-bilirubin score in non-malignant liver diseases
Sign Up to like & getrecommendations! Published in 2024 at "World Journal of Hepatology"
DOI: 10.4254/wjh.v16.i9.1308
Abstract: The albumin-bilirubin (ALBI) score is a useful prognostic marker that predicts mortality in patients suffering from terminal diseases. Recently, it has been reported that ALBI score is a predictor of non-malignant liver diseases. The cutoff… read more here.
Keywords: liver diseases; non malignant; score; malignant liver ... See more keywords